Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.
El Makhzangy H, Esmat G, Said M, Elraziky M, Shouman S, Refai R, Rekacewicz C, Gad RR, Vignier N, Abdel-Hamid M, Zalata K, Bedossa P, Pol S, Fontanet A, Mohamed MK.
El Makhzangy H, et al. Among authors: esmat g.
J Med Virol. 2009 Sep;81(9):1576-83. doi: 10.1002/jmv.21570.
J Med Virol. 2009.
PMID: 19626613
Clinical Trial.